Breaking News Instant updates and real-time market news.

2018-04-09 16:23:02 DK Delek US 16:23 04/09/18 04/09 16:23 04/09/18 16:23	Delek US initiated with an Outperform at Credit Suisse Credit Suisse analyst Manav Gupta initiated Delek US with an Outperform and $47 price target. Gupta said Delek is most levered to widening Midland-Cushing spread and its integrated nature of operations allows it to source discounted crudes and place refined products in niche markets. Further, Delek's logistics and retail assets diversify earnings streams and lower volatility.
DK Delek US 01/11/18 01/11/18 UPGRADE Target $44 Overweight Delek US upgraded to Overweight at Morgan Stanley As previously reported, Morgan Stanley analyst Benny Wong upgraded Delek US to Overweight from Equal Weight, saying he sees the company as positioned for better relative refining earnings given its locational advantage in the Permian. He also sees Delek US as quickly moving into a position to offer higher cash returns. Wong raised his price target on the stock to $44 from $34. 02/14/18 SBSH 02/14/18 UPGRADE Target $43 SBSH Buy Delek US upgraded to Buy from Neutral at Citi Citi analyst Prashant Rao upgraded Delek US to Buy after taking over coverage of the name. The analyst believes favorable Permian economics will drive "meaningful" free cash flow through 2020. He raised his price target for the shares to $43 from $41. 02/15/18 BOFA 02/15/18 UPGRADE BOFA Neutral Delek US upgraded to Neutral on stabilizing spreads at BofA/Merrill BofA/Merrill analyst Doug Leggate upgraded Delek US to Neutral from Underperform and increased its price target to $37 to reflect stabilizing spreads, recent asset sales, and share buy backs. 03/14/18 COWN 03/14/18 NO CHANGE COWN Tailwinds outstrip headwinds in refining outlook, says Cowen Cowen analyst Sam Margolin said he has a constructive refining outlook despite the current headwinds that include increased China capacity and a Brent/WTI compression. The analyst said the second half of the year should see those headwinds pass and said outside of global demand growth, MARPOL shipping industry regulations are requiring low sulfur marine fuel worldwide, and U.S. Tier-3 gasoline requirements could result in lower octane supply as a consequence of the de-sulferization processes. Margolin favors Valero (VLO), Phillips 66 (PSX), Delek (DK), Marathon (MPC), and Andeavor (ANDV) in the refining space.

2018-04-09 16:23:02

Delek US

16:23

04/09/18

04/09

16:23

04/09/18

16:23

Delek US initiated with an Outperform at Credit Suisse

Credit Suisse analyst Manav Gupta initiated Delek US with an Outperform and $47 price target. Gupta said Delek is most levered to widening Midland-Cushing spread and its integrated nature of operations allows it to source discounted crudes and place refined products in niche markets. Further, Delek's logistics and retail assets diversify earnings streams and lower volatility.

DK Delek US

01/11/18

02/14/18: SBSH

02/15/18: BOFA

03/14/18: COWN

TODAY'S FREE FLY STORIES

GOOG Alphabet $1,072.25 -2.17 (-0.20%) , GOOGL Alphabet Class A $1,075.28 -4.12 (-0.38%) 06:02 04/19/18 04/19 06:02 04/19/18 06:02 Periodicals	Google Pay surpasses 100M downloads on Play Store, Android Police says » Google Pay, called… GOOG Alphabet $1,072.25 -2.17 (-0.20%) GOOGL Alphabet Class A $1,075.28 -4.12 (-0.38%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Apr 23 Apr
INTC Intel $53.61 0.08 (0.15%) 06:01 04/19/18 04/19 06:01 04/19/18 06:01 Periodicals	Intel plans to shut down New Devices Group, The Information reports » Intel plans to shut down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ADMS Adamas Pharmaceuticals $25.86 0.86 (3.44%) 05:59 04/19/18 04/19 05:59 04/19/18 05:59 Hot Stocks	Adamas Pharmaceuticals announces final results from GOCOVRI Phase 3 study » Adamas Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Apr 25 Apr 25 Apr 12 Jun
TSLA Tesla $293.42 5.8 (2.02%) 05:55 04/19/18 04/19 05:55 04/19/18 05:55 Hot Stocks	Tesla batteries delivering power at 662 locations in Puerto Rico, Musk says » Tesla CEO Elon Musk… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
JPM JPMorgan $109.31 -0.9 (-0.82%) 05:55 04/19/18 04/19 05:55 04/19/18 05:55 Hot Stocks	JPMorgan Chase announces branch expansion in Greater Washington DC » JPMorgan Chase announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 May 30 May 13 Jul 12 Oct

ICLK iClick Interactive Asia $7.76 0.19 (2.51%) 05:55 04/19/18 04/19 05:55 04/19/18 05:55 Conference/Events	iClick Interactive Asia management to meet with Roth Capital » Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Apr 20 Apr
SBNY Signature Bank $135.08 -1.99 (-1.45%) 05:52 04/19/18 04/19 05:52 04/19/18 05:52 Hot Stocks	Signature Bank reports Q1 EPS ex-items $2.69, consensus $2.67 » Reports Q1 book value per… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Apr 25 Apr
SCCO Southern Copper $57.33 0.745 (1.32%) 05:50 04/19/18 04/19 05:50 04/19/18 05:50 Downgrade	Southern Copper rating change » Southern Copper… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Apr
FOXA 21st Century Fox $37.32 -0.22 (-0.59%) , DIS Disney $101.21 -1 (-0.98%) … 05:49 04/19/18 04/19 05:49 04/19/18 05:49 Hot Stocks	21st Century Fox rejected rival bid of $34.41 per share for assets » Disney (DIS) disclosed… FOXA 21st Century Fox $37.32 -0.22 (-0.59%) DIS Disney $101.21 -1 (-0.98%) CMCSA Comcast $33.28 0.02 (0.06%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Apr 08 May 09 May
NTRS Northern Trust $106.38 -0.04 (-0.04%) 05:47 04/19/18 04/19 05:47 04/19/18 05:47 Hot Stocks	Northern Trust enters partnership with The Northern Pool » The Northern Pool has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

NVS Novartis $81.72 -0.09 (-0.11%) , AMGN Amgen $175.14 0.19 (0.11%) 05:36 04/19/18 04/19 05:36 04/19/18 05:36 Hot Stocks	Novartis appoints John Tsai as Chief Medical Officer, Head of GDD » Novartis (NVS) announced… NVS Novartis $81.72 -0.09 (-0.11%) AMGN Amgen $175.14 0.19 (0.11%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Apr 24 Apr 30 Apr 17 May 21 May 28 May 05 Jun
AMZN Amazon.com $1,527.24 23.92 (1.59%) 05:36 04/19/18 04/19 05:36 04/19/18 05:36 Recommendations	Amazon.com analyst commentary » Amazon online retail… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Apr
NVS Novartis $81.72 -0.09 (-0.11%) 05:34 04/19/18 04/19 05:34 04/19/18 05:34 Earnings	Novartis confirms FY18 revenue guidance of growth of low to mid single-digit » Novartis noted,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Apr 17 May 21 May 05 Jun
NVS Novartis $81.72 -0.09 (-0.11%) 05:34 04/19/18 04/19 05:34 04/19/18 05:34 Hot Stocks	Novartis reports Q1 Alcon sales of $1.8B » Alcon net sales were… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Apr 17 May 21 May 05 Jun
RDN Radian Group $15.36 -0.91 (-5.59%) 05:30 04/19/18 04/19 05:30 04/19/18 05:30 Recommendations	Radian Group analyst commentary » Radian Group price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Apr

NVS Novartis $81.72 -0.09 (-0.11%) 05:29 04/19/18 04/19 05:29 04/19/18 05:29 Hot Stocks	Novartis Q1 results continue to demonstrate benefit from turnaround plan actions » Novartis noted, Q1… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Apr 17 May 21 May 05 Jun
MTG MGIC Investment $10.50 -0.275 (-2.55%) 05:29 04/19/18 04/19 05:29 04/19/18 05:29 Downgrade	MGIC Investment rating change » MGIC Investment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ESNT Essent Group $34.83 -2.045 (-5.55%) , MTG MGIC Investment $10.50 -0.275 (-2.55%) … 05:28 04/19/18 04/19 05:28 04/19/18 05:28 Downgrade	Essent Group, MGIC Investment, Radian Group rating change » Essent Group downgraded… ESNT Essent Group $34.83 -2.045 (-5.55%) MTG MGIC Investment $10.50 -0.275 (-2.55%) RDN Radian Group $15.36 -0.91 (-5.59%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Apr 04 May
NVS Novartis $81.72 -0.09 (-0.11%) 05:27 04/19/18 04/19 05:27 04/19/18 05:27 Hot Stocks	Novartis reports Q1 Sandoz net sales of $2.5B » Sandoz net sales were… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Apr 17 May 21 May 05 Jun
NVS Novartis $81.72 -0.09 (-0.11%) 05:25 04/19/18 04/19 05:25 04/19/18 05:25 Earnings	Novartis reports Q1 core EPS $1.28, consensus $1.29 » Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Apr 17 May 21 May 05 Jun

PG Procter & Gamble $78.19 -0.23 (-0.29%) , TEVA Teva $17.91 0.065 (0.36%) 05:23 04/19/18 04/19 05:23 04/19/18 05:23 Hot Stocks	Procter & Gamble acquires Consumer Health business of Merck KGaA for EUR 3.4B » Procter & Gamble (PG)… PG Procter & Gamble $78.19 -0.23 (-0.29%) TEVA Teva $17.91 0.065 (0.36%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Apr 27 Apr 18 May 05 Jun 16 Jun
GOL GOL Linhas $13.51 0.72 (5.63%) 05:22 04/19/18 04/19 05:22 04/19/18 05:22 Downgrade	GOL Linhas rating change » GOL Linhas downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PG Procter & Gamble $78.19 -0.23 (-0.29%) 05:22 04/19/18 04/19 05:22 04/19/18 05:22 Hot Stocks	Breaking Hot Stocks news story on Procter & Gamble » Procter & Gamble… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Apr 27 Apr
LN Line Corp. $38.30 0.09 (0.24%) 05:20 04/19/18 04/19 05:20 04/19/18 05:20 Downgrade	Line Corp. rating change » Line Corp. downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AAPL Apple $177.84 -0.41 (-0.23%) 05:16 04/19/18 04/19 05:16 04/19/18 05:16 Recommendations	Apple analyst commentary » Mizuho sees risk to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 May

Events

Earnings calls, analyst events, roadshows and more

Today at 08:00

Fed Reserve Governor Brainard Speaks at Forum Government Event

Ritz-Carlton Hotel, Washington, D.C.
GWPH
Today at 08:00

Peripheral & Central Nervous System Drugs Advisory Committee Meeting Government Event

FDA White Oak Conference Center--10903 New Hampshire Ave--Bldg 31--Great Room 1503 , Silver Spring, MD
BPFH
Today at 08:00

Boston Private Financial - BPFH Conference Calls
BBT
Today at 08:00

BB&T - BBT Conference Calls
PNR
Today at 08:00

Pentair - PNR Conference Calls
MDSO
Today at 08:00

Medidata - MDSO Conference Calls
DHR
Today at 08:00

Danaher - DHR Conference Calls
BK
Today at 08:00

BNY Mellon - BK Conference Calls
NURO
Today at 08:00

NeuroMetrix - NURO Conference Calls
AN
Today at 08:00

AutoNation Firm Sponsored Meetings

Co Offices--200 SW 1st Avenue, Fort Lauderdale, FL

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CLVS X CLVS Clovis Secondary Managers: JPMorgan & BofA/Merrill Priced at: $54.41 1.838M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TMQ X TMQ Trilogy Metals Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.16 21.552M Shares
Tues	BLCM X BLCM Bellicum Pharmaceuticals Secondary Managers: Citi & Jefferies Priced at: $7.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MBII X MBII Marrone Bio Spot Secondary Managers: National Securities Priced at: $1.65 7.275M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	EAF X EAF GrafTech IPO Managers: JPMorgan, Credit Suisse, Citi, RBC Capital & HSBC, BMO Capital, BNP Paribas, CIBC, National Bank, TD Securities Priced at: $15.00 35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MOR X MOR MorphoSys IPO Managers: Goldman Sachs, JPMorgan & Leerink, Berenberg Capital, JMP Securities Priced at: $25.04 8.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SURF X SURF Surface Oncology IPO Managers: Goldman Sachs, Cowen & Evercore ISI Priced at: $15.00 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SJI X SJI South Jersey Industries Secondary Managers: BofA/Merrill, Guggenheim & Wells Fargo, JPMorgan, Morgan Stanley, PNC Capital, TD Securities Priced at: $29.50 11.017M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	MREO X MREO Mereo BioPharma IPO Managers: Cowen, BMO Capital & RBC Capital, Cantor Fitzgerald $17.62 2.838M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRIO X VRIO Vrio IPO Managers: Goldman Sachs, JPMorgan, Citi & Morgan Stanley, BofA/Merrill, Barclays, BTG Pactual, Credit Suisse, Deutsche Bank, Itau BBA, Santander, BBSI, PARI, BBBI $16.00-17.00 29.684M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGLE X AGLE Aeglea BioTherapeutics Secondary Managers: Evercore ISI & BMO Capital, Jones Trading $9.34 4.5M Shares APLS X APLS Apellis Secondary Managers: Citi, JPMorgan & Cowen $30.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CART X CART Carolina Trust BancShares Secondary Managers: Sandler ONeill $9.08 2.2M Shares ASPU X ASPU Aspen Group Spot Secondary Managers: Roth Capital $7.59 HMNY X HMNY Helios and Matheson Spot Secondary Managers: Canaccord $3.83 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRCH X TRCH Torchlight Energy Resources Spot Secondary Managers: Roth Capital $1.33
Thurs	FCI X FCI FirstCaribbean IPO Managers: Barclays, UBS & CIBC, Keefe Bruyette, Raymond James, Sandler ONeill, Wells Fargo $22.00-25.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LEVL X LEVL Level One IPO Managers: Raymond James & Keefe Bruyette, Piper Jaffray $27.090-29.00 1M Shares PVTL X PVTL Pivotal Software IPO Managers: Morgan Stanley, Goldman Sachs & Citi, BofA/Merrill, Barclays, Credit Suisse, RBC Capital, UBS, Wells Fargo, KeyBanc, William Blair, Mischler, Ramirez, Siebert Cisneros, Williams Capital $14.00 - 16.00 37M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RIGL X RIGL Rigel Pharmaceuticals Secondary Managers: Jefferies, Piper Jaffray & BMO Capital, H.C. Wainwright $3.88 15M Shares
Fri	No deals

View All Syndicate Announcements »

Delek US initiated with an Outperform at Credit Suisse

TODAY'S FREE FLY STORIES

Get Full Fly Access